Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Upstream Processing01:27

Upstream Processing

Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anti-genes: siRNA, ribozymes and antisense.

Current pharmaceutical biotechnology·2004
Same author

Construction and transfection of a ribozyme targeting human caspase-3.

Anticancer research·2004
Same author

Cancer gene therapy: challenges and opportunities.

Anticancer research·2004
Same author

Ribozyme against mutant K-ras mRNA suppresses tumor growth of pancreatic cancer.

International journal of oncology·2004
Same author

Reversal of drug resistance using hammerhead ribozymes against multidrug resistance-associated protein and multidrug resistance 1 gene.

International journal of oncology·2002
Same journal

Iodine-125 seed induces ferroptosis through inhibiting RNF216-mediated ubiquitination of p53 in cholangiocarcinoma cells.

Cytotechnology·2026
Same journal

Magnetic resonance imaging-based Alzheimer's disease detection using an EfficientNet-CMSACCN framework.

Cytotechnology·2026
Same journal

Brusatol Induces Ferroptosis in Condyloma Acuminatum Keratinocytes by Suppressing Nrf2 via Inhibition of the PI3K/AKT Pathway.

Cytotechnology·2026
Same journal

The inhibitory effect of curcumin on airway inflammation in mice with chronic obstructive pulmonary disease and its mechanism: a study based on the PPARγ/AMPK/mTORC1 pathway.

Cytotechnology·2026
Same journal

Based on comprehensive analysis of ScRNA-seq and bulk RNA-seq, identification of palmitoylation-related genes as biomarkers to evaluate prognosis and immune landscape in stomach adenocarcinoma.

Cytotechnology·2026
Same journal

Transcriptomics identifies mild hyperthermia-conditioned tumor supernatant as an inducer of HepG2 transition.

Cytotechnology·2026
See all related articles

Related Experiment Video

Updated: Jun 28, 2026

Development of New Therapeutic Applications Using Microfluidics
08:56

Development of New Therapeutic Applications Using Microfluidics

Published on: October 1, 2007

Commercializing medical technology.

Kevin J Scanlon1, Mark A Lieberman

  • 1International BioScience, Business Technology Center, 2400 N. Lincoln Ave, Altadena, CA, 91001, USA, kjs222@earthlink.net.

Cytotechnology
|November 13, 2008
PubMed
Summary
This summary is machine-generated.

A synergy between science and business accelerates medical innovation. Historical analysis shows Germany, Britain, and the US leading in medical advances through education-business collaboration, with emerging global competition in biotechnology.

More Related Videos

Rapid and Low-cost Prototyping of Medical Devices Using 3D Printed Molds for Liquid Injection Molding
10:43

Rapid and Low-cost Prototyping of Medical Devices Using 3D Printed Molds for Liquid Injection Molding

Published on: June 27, 2014

Human Mesenchymal Stem Cell Processing for Clinical Applications Using a Closed Semi-Automated Workflow
09:03

Human Mesenchymal Stem Cell Processing for Clinical Applications Using a Closed Semi-Automated Workflow

Published on: March 17, 2023

Related Experiment Videos

Last Updated: Jun 28, 2026

Development of New Therapeutic Applications Using Microfluidics
08:56

Development of New Therapeutic Applications Using Microfluidics

Published on: October 1, 2007

Rapid and Low-cost Prototyping of Medical Devices Using 3D Printed Molds for Liquid Injection Molding
10:43

Rapid and Low-cost Prototyping of Medical Devices Using 3D Printed Molds for Liquid Injection Molding

Published on: June 27, 2014

Human Mesenchymal Stem Cell Processing for Clinical Applications Using a Closed Semi-Automated Workflow
09:03

Human Mesenchymal Stem Cell Processing for Clinical Applications Using a Closed Semi-Automated Workflow

Published on: March 17, 2023

Area of Science:

  • Medical innovation and biotechnology
  • History of science and education
  • Science-business synergy

Background:

  • Medicine experiences 50-year innovation cycles driven by education and scientific discovery.
  • Historical models of synergy between education and industry, such as Germany's technical colleges in the 1880s, fostered scientific dominance.
  • The migration of scientists influenced national scientific leadership, from Germany to Britain and then to the US.

Purpose of the Study:

  • To analyze the historical interplay between education, business, and scientific advancement in medicine.
  • To examine the factors contributing to national leadership in medical innovation and biotechnology.
  • To predict future trends in global scientific and educational leadership in the 21st century.

Main Methods:

  • Historical analysis of scientific and educational developments across different nations.
  • Examination of the impact of scientist migration on national research and development.
  • Review of government policies and industry-education collaborations in biotechnology.

Main Results:

  • Germany's early synergy between chemical industry and technical colleges led to international scientific dominance (1880-1930).
  • The US became a center for medical advances and biotechnology post-WWII due to government funding and influx of European scientists.
  • International scientists trained in the US are returning to Europe and Asia, where governments actively support biotechnology.

Conclusions:

  • The historical success of medical innovation is linked to strong synergy between education, industry, and government.
  • The US faces increasing competition in biotechnology as other nations invest in and foster this sector.
  • Future leadership in science and education will depend on adapting educational systems to new synergistic models and government support for innovation.